Cargando…
Primary Diffuse Large B-Cell Lymphoma of the Bone
Primary lymphoma of the bone (PLB) is a rare lymphoproliferative neoplasm that can present either as solitary or multiple bone lesions. We report four patients with PLB who were successfully treated with R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone) followed by conso...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10181325/ https://www.ncbi.nlm.nih.gov/pubmed/37187495 http://dx.doi.org/10.14740/jh1087 |
_version_ | 1785041547501240320 |
---|---|
author | Yohannan, Binoy Rios, Adan |
author_facet | Yohannan, Binoy Rios, Adan |
author_sort | Yohannan, Binoy |
collection | PubMed |
description | Primary lymphoma of the bone (PLB) is a rare lymphoproliferative neoplasm that can present either as solitary or multiple bone lesions. We report four patients with PLB who were successfully treated with R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone) followed by consolidative radiotherapy. All patients achieved a complete remission and had excellent long-term outcomes. PLB has a favorable response to combined modality treatment with chemoimmunotherapy and radiation. Long-term outcomes of PLB tend to be better than those of non-osseous diffuse large B-cell lymphoma. |
format | Online Article Text |
id | pubmed-10181325 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elmer Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-101813252023-05-13 Primary Diffuse Large B-Cell Lymphoma of the Bone Yohannan, Binoy Rios, Adan J Hematol Case Report Primary lymphoma of the bone (PLB) is a rare lymphoproliferative neoplasm that can present either as solitary or multiple bone lesions. We report four patients with PLB who were successfully treated with R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone) followed by consolidative radiotherapy. All patients achieved a complete remission and had excellent long-term outcomes. PLB has a favorable response to combined modality treatment with chemoimmunotherapy and radiation. Long-term outcomes of PLB tend to be better than those of non-osseous diffuse large B-cell lymphoma. Elmer Press 2023-04 2023-03-25 /pmc/articles/PMC10181325/ /pubmed/37187495 http://dx.doi.org/10.14740/jh1087 Text en Copyright 2023, Yohannan et al. https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Non-Commercial 4.0 International License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Yohannan, Binoy Rios, Adan Primary Diffuse Large B-Cell Lymphoma of the Bone |
title | Primary Diffuse Large B-Cell Lymphoma of the Bone |
title_full | Primary Diffuse Large B-Cell Lymphoma of the Bone |
title_fullStr | Primary Diffuse Large B-Cell Lymphoma of the Bone |
title_full_unstemmed | Primary Diffuse Large B-Cell Lymphoma of the Bone |
title_short | Primary Diffuse Large B-Cell Lymphoma of the Bone |
title_sort | primary diffuse large b-cell lymphoma of the bone |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10181325/ https://www.ncbi.nlm.nih.gov/pubmed/37187495 http://dx.doi.org/10.14740/jh1087 |
work_keys_str_mv | AT yohannanbinoy primarydiffuselargebcelllymphomaofthebone AT riosadan primarydiffuselargebcelllymphomaofthebone |